Rankings
▼
Calendar
RMD Q4 2021 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena
RMD
ResMed Inc.
$36B
Q4 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$876M
+13.7% YoY
Gross Profit
$491M
56.0% margin
Operating Income
$242M
27.6% margin
Net Income
$195M
22.3% margin
EPS (Diluted)
$1.33
QoQ Revenue Growth
+14.0%
Cash Flow
Operating Cash Flow
$227M
Free Cash Flow
$196M
Stock-Based Comp.
$17M
Balance Sheet
Total Assets
$4.7B
Total Liabilities
$1.8B
Stockholders' Equity
$2.9B
Cash & Equivalents
$295M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$876M
$770M
+13.7%
Gross Profit
$491M
$449M
+9.2%
Operating Income
$242M
$223M
+8.2%
Net Income
$195M
$178M
+9.7%
Revenue Segments
Sleep And Respiratory
$780M
89%
Software As Service
$96M
11%
Geographic Segments
Global
$876M
100%
← FY 2021
All Quarters
Q1 2022 →